MedTrace Logo

Effect of Stroboscopic Balance Training on Chronic Ankle Instability in Volleyball Players

NCT07255625 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-03-03

No results posted yet for this study

Summary

Effect of Stroboscopic Balance Training on Chronic Ankle Instability in Volleyball Players

Conditions

  • Chronic Ankle Instability

Interventions

DEVICE

Balance training with stroboscopic glasses

Participants in Group A completed a supervised, multi-modal balance training program while wearing Senaptec stroboscopic glasses (Beaverton, Oregon), set to a duty cycle of 100 ms transparent followed by 150 ms opaque. The glasses use liquid crystal lenses that alternate between clear and nearly opaque states when electrically activated and can operate in both binocular and monocular modes, with settings adjustable via a Bluetooth application. The program, targeting static and dynamic balance in individuals with chronic ankle instability, consisted of six progressively challenging exercises performed indoors, barefoot, in small groups, lasting approximately 20 minutes per session, twice weekly for eight weeks. Exercises were completed in two sets with 30-second rests between exercises and 2-minute rests between sets, and progression was adjusted based on participant performance.

OTHER

Traditional Balance Training

The intervention consisted of a supervised, multi-modal balance training program targeting differentaspects of static and dynamic balance for participants with chronic ankle instability. The program included six progressively challenging exercises, administered under the supervision of a physiotherapist. Each session lasted approximately 20 minutes, and participants completed two sessions per week for eight weeks. The training was conducted indoors, barefoot, in small groups, with exercises performed in two sets, including 30-second rests between exercises and 2-minute rests between sets. Progression was implemented according to participants' performance throughout the program.

Sponsors & Collaborators

  • Biruni University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
26 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-20
Primary Completion
2026-02-20
Completion
2026-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07255625 on ClinicalTrials.gov